rs1870050, GLDN

N. diseases: 5
Disease: Metastatic Prostate Carcinoma ×
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
Metastatic Prostate Carcinoma
CUI: C0936223
Disease: Metastatic Prostate Carcinoma
0.010 GeneticVariation BEFREE These findings suggest that genetic variation in CYP19A1 (rs1870050) might affect the prognosis of patients with metastatic prostate cancer when treated with ADT by regulating serum testosterone levels. 30868236 2019